{"schema_version":"secwatch.filing_event.v1","accession":"0001099800-25-000046","form_type":"8-K","ticker":"EW","cik":"0001099800","company_name":"Edwards Lifesciences Corp","filed_at":"2025-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.340938+00:00","generated_at":"2026-05-17T18:53:27.017620+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"FTC moves to block Edwards' proposed JenaValve acquisition; Edwards raises FY2025 adjusted EPS guidance to $2.45-$2.55","bullets":["FTC moved to block Edwards' proposed acquisition of JenaValve Technology; Edwards disagrees and will continue pursuing regulatory approval.","Edwards estimates a final determination on the acquisition by end of Q1 2026.","Full-year 2025 adjusted EPS guidance raised to high-end of $2.45-$2.55 (from $2.40-$2.50); revenue guidance unchanged.","Minimal impact to Q3 2025 adjusted EPS guidance from FTC action."],"urls":{"canonical":"https://secwatch.observer/filing/0001099800-25-000046","json":"https://secwatch.observer/filing/0001099800-25-000046.json","markdown":"https://secwatch.observer/filing/0001099800-25-000046.md","text":"https://secwatch.observer/filing/0001099800-25-000046.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1099800/000109980025000046/0001099800-25-000046-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1099800/000109980025000046/ew-20250806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T18:53:27.017620+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}